Gm. Adamson et Re. Billings, TUMOR-NECROSIS-FACTOR - RECEPTOR-BINDING AND EXPRESSION OF RECEPTORS IN CULTURED MOUSE HEPATOCYTES, The Journal of pharmacology and experimental therapeutics, 269(1), 1994, pp. 367-373
Recombinant murine tumor necrosis factor (TNF-alpha) was labeled with
I-125 and used to determine the binding characteristics, internalizati
on and intracellular degradation in cultured mouse hepatocytes. [I-125
]TNF-alpha bound specifically to hepatocytes and Scatchard analysis of
the data indicated binding to both a low-affinity (K-d = 20 nM) high
capacity (51225 sites/cell) component and high-affinity component (K-d
= 4 pM), with low capacity (290 sites/cell). The extent of TNF-alpha
binding to hepatocytes correlated closely with its biological activity
in hepatocytes, as indexed by depletion of intracellular ATP. At conc
entrations lower than 0.06 nM there was minimal binding and no effect
on cellular ATP, whereas maximal binding at concentrations greater tha
n 45 nM caused 80% depletion (in comparison to controls) of hepatocyte
ATP. Incubation at 37 degrees C resulted in rapid uptake, internaliza
tion and degradation of [I-125]TNF-alpha. This was followed by release
of degraded material from hepatocytes. Examination, by reverse transc
riptase/polymerase chain reaction technology, of hepatocyte RNA extrac
ted after the 4-hr adherence period revealed that mouse hepatocytes ex
pressed mRNA for both TNF-alpha receptor 1 and TNF-alpha receptor 2, a
nd that the relative abundance of TNF-alpha receptor 1 was approximate
ly 7-fold greater than that for TNF-alpha receptor 2. Because it has b
een shown that these receptors have different affinities for TNF-alpha
, this may explain the high- and low-affinity binding sites present on
cultured mouse hepatocytes.